Potential Side Effects of Common Rheumatoid Arthritis Medications

Methotrexate, a commonly prescribed medication for rheumatoid arthritis, has been known to cause acute pneumonitis and interstitial lung disease. Although this is a rare complication, it can be fatal and should be closely monitored. Azathioprine, another medication used to treat rheumatoid arthritis, can lead to bone marrow suppression and increase the risk of infection. Cyclosporin, often used in combination with other medications, can cause neurological and visual disturbances. Hydroxychloroquine, while generally well-tolerated, can lead to abdominal pain and visual disturbances in cases of toxicity. Sulfasalazine, another medication used to treat rheumatoid arthritis, can affect liver function tests and cause bone marrow suppression, requiring careful monitoring.

It is important for patients to be aware of the potential side effects of their medications and to communicate any concerns with their healthcare provider. Regular monitoring and follow-up appointments can help to identify and manage any adverse effects. With proper management, the benefits of these medications can outweigh the risks for many patients with rheumatoid arthritis.

Osteoarthritis in the Hand and Elbow

Osteoarthritis (OA) is a prevalent form of arthritis that commonly affects the hand, particularly the joints. The joints may exhibit several deformities, including the development of small bone spurs called nodes. These nodes are referred to as Heberden’s nodes when they occur at the joint next to the fingernail and Bouchard’s nodes when they occur at the middle joints. The base of the thumb may also appear squared off, accompanied by swelling and tenderness. Soft tissue laxity can result in instability at the base of the thumb.

In contrast, elbow OA is relatively uncommon.

Migratory tenosynovitis can be caused by disseminated gonococcal infection in younger adults, particularly women. It is important to test for C6-C9 complement deficiency. Rheumatoid arthritis can also cause tenosynovitis, but it is not migratory and is usually found in the interphalangeal, metacarpophalangeal, and wrist joints. Scleroderma can cause tenosynovitis, but it is not migratory either. Fluoroquinolone toxicity may increase the risk of tendinopathy and tendon rupture, but it does not cause migratory tenosynovitis. Reactive arthritis can cause tendinitis, but it is more prevalent in men and is not migratory. It is a rheumatoid factor-seronegative arthritis that can be linked with HLA-B27.

Understanding Reactive Arthritis and Differential Diagnosis

Reactive arthritis is a condition characterized by the presence of urethritis, arthritis, and conjunctivitis. It typically occurs 1-3 weeks after an initial infection, with Chlamydia trachomatis and Salmonella, Shigella, and Campylobacter being the most common causative agents. In addition to the classic triad of symptoms, patients may also experience keratoderma blennorrhagica and buccal and lingual ulcers.

When considering differential diagnoses, it is important to note that inflammatory arthritides can be seropositive or seronegative. Seronegative spondyloarthritides include ankylosing spondylitis, psoriatic arthritis, enteropathic arthritis, reactive arthritis, and gonococcal arthritis.

Gonococcal arthritis is a form of septic arthritis that typically affects a single joint and presents with a hot, red joint and systemic signs of infection. Ankylosing spondylitis, on the other hand, does not present with any clinical features in this patient. Enteropathic arthritis is associated with inflammatory bowel disease, which is less likely in a patient with a recent history of travel and diarrhea. Psoriatic arthritis is unlikely to present simultaneously with psoriasis in a young, previously healthy patient without any prior history of either condition.

Osteoarthrosis and Common Deformities in the Hand

Osteoarthrosis (OA) is a prevalent type of arthritis that often affects the hand. Upon examination of the joints, it is common to find small bone spurs known as nodes on the tops of joints. These nodes can take on different names depending on their location. For instance, if they occur at the joint next to the fingernail, they are called Heberden’s nodes. On the other hand, if they occur at the PIP joints, they are referred to as Bouchard’s nodes. It is worth noting that shoulder joint involvement is rare in OA.

The Role of Human Leukocyte Antigens in Autoimmune Diseases

Human leukocyte antigens (HLAs) play a crucial role in the development of autoimmune diseases. Different HLAs are associated with specific autoimmune conditions. For example, HLA-B27 is present in 90% of patients with ankylosing spondylitis, as well as reactive arthritis and acute anterior uveitis. HLA-Cw6 is associated with psoriasis vulgaris, while HLA-B8 is linked to hyperthyroidism (Graves’ disease). HLA-DR4 is associated with rheumatoid arthritis and type 1 diabetes mellitus, and HLA-DR2 is linked to systemic lupus erythematosus (SLE) in Japanese people, multiple sclerosis, and Goodpasture syndrome. Understanding the role of HLAs in autoimmune diseases can help with diagnosis and treatment.

Treatment Options for Rheumatoid Disease: A Comparison of Biological Therapies and DMARDs

Rheumatoid disease can be a debilitating condition that requires careful management. When standard disease-modifying anti-rheumatic drugs (DMARDs) fail to provide relief, biological therapies may be prescribed. Infliximab, adalimumab, and etanercept are some of the contemporary biological therapies available. Infliximab, in particular, is often co-prescribed with methotrexate, although it may cause a reversible lupus-like syndrome and tuberculosis reactivation.

Combining gold, leflunomide, and methotrexate is unlikely to help patients who have already failed DMARD therapy. Azathioprine may be considered in severe cases, but biological therapy is the preferred treatment when intensive DMARD therapy fails. The combination of gold and penicillamine is a viable option for patients who meet the criteria for biological therapy, according to National Institute for Health and Care Excellence (NICE) guidelines. DMARD monotherapy, such as leflunomide, is only recommended when dual therapy is contraindicated.

In summary, the choice of treatment for rheumatoid disease depends on the severity of the condition and the patient’s response to previous therapies. Biological therapies may offer relief for patients who have failed DMARD therapy, but careful monitoring for potential side effects is necessary.

Treatment Options for Fibromyalgia Patients

Fibromyalgia is a chronic condition that causes widespread pain, increased sensitivity to pain, and psychological symptoms. Treatment options can be divided into generic and patient-focused treatments. Aerobic exercise is a first-line, generic treatment that has been shown to improve symptoms of pain and physical function. Cognitive behavioral therapy (CBT) is a patient-focused treatment that may be considered for patients with pain-related depression, anxiety, catastrophizing, and/or passive or active coping strategies. Anaerobic exercise should be avoided as it may increase inflammation and oxidative stress. Duloxetine and pregabalin are pharmacotherapy options for patients with severe pain or sleep disturbance, but only after non-pharmacological treatments have failed. It is important to tailor treatment to each patient’s individual needs.

Treatment Options for Fibromyalgia Patients

Spondyloarthritis: A Group of Related Disorders

The patient’s history suggests the presence of spondyloarthritis, which is a group of related but distinct disorders. These include ankylosing spondylitis, reactive arthritis, psoriatic arthritis, and a subgroup of juvenile idiopathic arthritis. HLA-B27 is a predisposing factor for all these disorders and is present in a high percentage of patients with ankylosing spondylitis and reactive arthritis. Ankylosing spondylitis is a severe form of spondyloarthritis that mainly affects the entheses and leads to spinal immobility. TNF-antagonists are the primary treatment, but physiotherapy and non-steroidal anti-inflammatory agents also have a role.

Reactive arthritis is the most common type of inflammatory polyarthritis in young men and is an important differential diagnosis in this case. It typically follows genitourinary infection with Chlamydia trachomatis or enteric infections with certain strains of Salmonella or Shigella. Treatment with doxycycline can sometimes shorten the course of the disease if associated with Chlamydia infection. In general, non-steroidal anti-inflammatories are used for treatment, with intra-articular corticosteroids if large joints are involved.

In conclusion, spondyloarthritis is a group of related disorders that share a common predisposing factor and can cause significant morbidity. Ankylosing spondylitis and reactive arthritis are two of the most common types, and their diagnosis should be considered in patients with suggestive symptoms. Treatment options include TNF-antagonists, non-steroidal anti-inflammatory agents, and physiotherapy.

Differential Diagnosis for a Young Man with Purpura and Haematuria

The patient in question presents with a purpuric rash on the back, buttocks, and extensor surfaces of the lower limbs, as well as haematuria. The following is a differential diagnosis of possible conditions that could be causing these symptoms.

Henoch–Schönlein purpura (HSP)
The clinical presentation is entirely typical of HSP, a vasculitic process that results in a purpuric rash and haematuria. It should be noted that platelet numbers are usually normal or raised in HSP, so thrombocytopaenia is not expected.

Haemophilia A
This condition is not likely as it results in joint and muscle bleeding, which is not present in this case. Additionally, haemophilia would not cause haematuria.

Idiopathic thrombocytopaenic purpura (ITP)
While purpura is a symptom of ITP, a reduced platelet count is typically present. Without a discussion of platelet levels, it is difficult to justify a diagnosis of ITP. Additionally, ITP would not result in haematuria.

Leukaemia
If acute leukaemia were causing the symptoms, thrombocytopaenia might be expected. However, the clinical presentation is more compatible with HSP, and thrombocytopaenia alone would not result in haematuria.

Thalassaemia trait
There is no indication in the history to suggest this condition, and it would not result in purpura. Thalassaemia trait is typically asymptomatic.

In conclusion, the patient’s symptoms are most consistent with HSP, a vasculitic process that results in a purpuric rash and haematuria.